Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature
Non-small cell lung cancer (NSCLC) represents more than about 80% of the lung cancer. The early stages of NSCLC can be treated with complete resection with a good prognosis. However, most cases are detected at...